<Record>
<Term>Tazarotene</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<SemanticType>Organic Chemical</SemanticType>
<ParentTerm>Retinoic Acid Agent</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Antineoplastic Agent/Cell Differentiating Agent/Differentiation Inducer/Retinoic Acid Agent/Tazarotene</ClassificationPath>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Cell Differentiating Agent</BroaderTerm>
<BroaderTerm>Antineoplastic Agent</BroaderTerm>
<BroaderTerm>Tazarotene</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Differentiation Inducer</BroaderTerm>
<BroaderTerm>Retinoic Acid Agent</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>Retisol-A</Synonym>
<Synonym>6-[(3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]- 3-Pyridinecarboxylic Acid, Ethyl Ester</Synonym>
<Synonym>Tazarotene</Synonym>
<Synonym>TAZAROTENE</Synonym>
<Synonym>Tazorac</Synonym>
<Synonym>Ethyl 6-(2-(4,4-Dimethylthiochroman-6-yl)ethynyl)nicotinate</Synonym>
<Synonym>Stieva-A Forte</Synonym>
<Synonym>Avage</Synonym>
<Synonym>Vitinoin</Synonym>
<Synonym>AGN-190168</Synonym>
<Synonym>Stieva-A</Synonym>
<Description>A synthetic, topical retinoid.  Tazarotene induces the expression of tazarotene-induced gene 3 (TIG3), a tumor suppressor gene.  In psoriasis, tazarotene normalizes abnormal keratinocyte differentiation and reduces their hyperproliferation. (NCI04)</Description>
<Source>FDA Registry</Source>
<Source>NCI Thesaurus</Source>
</Record>
